Radnostix (INIS) Research & Development (2010 - 2026)
Radnostix (INIS) reported Research & Development of $114,774 for Q2 2026, up 11.8% from $102,661 a year earlier but down 23.0% from the prior quarter.
Powered by 
Analysis
Radnostix (INIS) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Radnostix's Research & Development came in at $490,378, up 10.7% year-over-year; for FY2025, it was $435,840, down 28.6% from FY2024.
- Research & Development has a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
- By year, Research & Development came in at $610,737 in FY2024 (+5.8%), $577,354 in FY2023 (+8.2%), $533,716 in FY2022 (+96.4%) and $271,714 in FY2021 (+23.8%).
- Five-year quarterly Research & Development spans a low of $73,886 in Q3 2021 and a high of $206,414 in Q1 2022.
- Year over year, Research & Development gained in four of the last eight quarters, with an average decline of 7.3%.
- The high point for year-over-year Research & Development in five years was Q1 2022 (growth of 454.3%); the low point was Q2 2025 (a decline of 45.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $149,128 (Q1 2026), $87,065 (Q4 2025) and $139,411 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Radnostix | 20.37 Mn | 14.48 Mn | 1.36 Mn | 114,774.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114,774.00 |
| Mar 31, 2026 | 149,128.00 |
| Dec 31, 2025 | 87,065.00 |
| Sep 30, 2025 | 139,411.00 |
| Jun 30, 2025 | 102,661.00 |
| Mar 31, 2025 | 106,703.00 |
| Dec 31, 2024 | 121,409.00 |
| Sep 30, 2024 | 112,351.00 |
| Jun 30, 2024 | 188,730.00 |
| Mar 31, 2024 | 188,247.00 |
| Dec 31, 2023 | 169,342.00 |
| Sep 30, 2023 | 100,544.00 |
| Jun 30, 2023 | 183,024.00 |
| Mar 31, 2023 | 124,442.00 |
| Dec 31, 2022 | 91,333.00 |
| Sep 30, 2022 | 148,327.00 |
| Jun 30, 2022 | 87,642.00 |
| Mar 31, 2022 | 206,414.00 |
| Dec 31, 2021 | 88,612.00 |
| Sep 30, 2021 | 73,886.00 |
API Access
Radnostix Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=INIS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "INIS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=INIS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();